In order to identify the antigen specificity of TILs after CTI therapy of B16 melanoma, we investigated the interferon (IFN)-γ production ability using melanoma antigen peptides such as TRP-1222–229, TRP-2180–188 and gp10025–33. This evidence concerns the gene IFNG and melanoma.